Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

about

Targeted drugs in small-cell lung cancer EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.eIF4E Phosphorylation in Prostate Cancer.Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors.

P2860

Q26767017-D51CC631-B54A-4BE7-9B48-3FEB9BC022A4 Q37366277-04338A23-B035-4333-9D9E-554F14937A72 Q53687330-8BFDB06C-A48A-4BA2-8471-26A85555E66A Q55141745-A25F95EA-EE50-4CFA-8E49-45BFA6B651F1

P2860

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

Item

http://www.wikidata.org/entity/Q35605425

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

@ast

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

@en

type

Item

label

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

@ast

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

@en

prefLabel

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

@ast

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

@en

P1476

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

@en

P2093

Akihiko Gemma

http://www.w3.org/2001/XMLSchema#string

Akihiko Miyanaga

http://www.w3.org/2001/XMLSchema#string

Chie Soeno

http://www.w3.org/2001/XMLSchema#string

Kaoru Kubota

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Kitamura

http://www.w3.org/2001/XMLSchema#string

Masahiro Seike

http://www.w3.org/2001/XMLSchema#string

Masaru Matsumoto

http://www.w3.org/2001/XMLSchema#string

Rintaro Noro

http://www.w3.org/2001/XMLSchema#string

Susumu Takeuchi

http://www.w3.org/2001/XMLSchema#string

Teppei Sugano

http://www.w3.org/2001/XMLSchema#string

P2860

Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules.

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Cancer statistics, 2013

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

P2888

s12885-015-1202-4

P304

241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-015-1202-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275048479

http://www.w3.org/2001/XMLSchema#string

P6179

1051150891

http://www.w3.org/2001/XMLSchema#string

P698

25884680

http://www.w3.org/2001/XMLSchema#string

P932

4414307

http://www.w3.org/2001/XMLSchema#string

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

about

P2860

P2860

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P5875

P6179

P698

P932